Hims & Hers Health, Inc.
HIMSDrug Manufacturers - Specialty & Generic
$27.68−6.71%As of Oct 30vs prior close
- Market cap
- $6.5B
- P/E (TTM)
- –
- P/E (FY1)
- 98.0×
- From 52W high
- −39.11%
- EPS (LTM)
- -$0.63
- Revenue (LTM)
- $2.6B
- Net margin
- -5.51%
- Dividend yield
- 0.00%
Nomior Score
33
Speculative ChargeSpeculativeBottom 19% of the scored universe
Growth74
Quality44
Value29
Momentum28
Resilience29
Growth
+74.71%revenue a year over 6 fiscal years
YE19 $82.6MLTM $2.6B
Connections
Revenue to profitQ2 YE26
The operating loss was 13% of revenue, wider by 18 pts on a year.
Who owns it
3funds